Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
7061946
Reference Type
Journal Article
Subtype
Review
Title
Pharmacological activities of dihydrotanshinone I, a natural product from Salvia miltiorrhiza Bunge
Author(s)
Chen, X; Yu, Jie; Zhong, B; Lu, J; Lu, J; Li, S; Lu, Y; ,
Year
2019
Is Peer Reviewed?
1
Journal
Pharmacological Research
ISSN:
1043-6618
EISSN:
1096-1186
Publisher
ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
Location
LONDON
Volume
145
Page Numbers
104254
Language
English
PMID
31054311
DOI
10.1016/j.phrs.2019.104254
Web of Science Id
WOS:000475721100004
Abstract
Salvia miltiorrhiza Bunge (Danshen), a famous traditional Chinese herb, has been used clinically for the treatment of various diseases for centuries. Document data showed that tanshinones, a class of lipophilic abietane diterpenes rich in this herb, possess multiple biological effects in vitro and in vivo models. Among which, 15,16-dihydrotanshinone I (DHT) has received much attention in recent years. In this systematical review, we carefully selected, analyzed, and summarized high-quality publications related to pharmacological effects and the underlying mechanisms of DHT. DHT has anti-cancer, cardiovascular protective, anti-inflammation, anti Alzheimer's disease, and other effects. Furthermore, several molecules such as hypoxia-inducible factor (HIF-1 alpha), human antigen R (HuR), acetylcholinesterase (AchE), etc. have been identified as the potential targets for DHT. The diverse pharmacological activities of DHT provide scientific evidence for the local and traditional uses of Salvia miltiorrhiza Bunge. We concluded that DHT might serve as a lead compound for drug discovery in related diseases while further in-depth investigations are still needed.
Keywords
15,16-Dihydrotanshinone I; Anti-cancer; Anti-inflammation; Cardiovascular protection; Human antigen R; Hypoxia-inducible factor
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity